In the BioHarmony Drug Report Database
Nystatin
Candex, Mycostatin, Nilstat, Nysert (nystatin) is a small molecule pharmaceutical. Nystatin was first approved as Candex on 1982-01-01. It is used to treat chronic mucocutaneous candidiasis, cutaneous candidiasis, mycoses, oral candidiasis, and vulvovaginal candidiasis in the USA.
Trade Name
|
Candex, Mycostatin, Nilstat, Nysert |
|---|---|
Common Name
|
nystatin |
ChEMBL ID
|
CHEMBL450895 |
Indication
|
chronic mucocutaneous candidiasis, cutaneous candidiasis, mycoses, oral candidiasis, vulvovaginal candidiasis |
Drug Class
|
Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors) |
Image (chem structure or protein)